U.S. markets closed

Iridium World Communications Ltd. (IRIDQ)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.0600+0.0550 (+1,100.00%)
At close: 2:03PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close0.0050
Open0.0500
BidN/A x N/A
AskN/A x N/A
Day's Range0.0500 - 0.0600
52 Week Range0.0000 - 0.1100
Volume9,001
Avg. Volume2,629
Market Cap1.14M
Beta (5Y Monthly)15.94
PE Ratio (TTM)N/A
EPS (TTM)-11.1840
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
View more
  • SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of SNSS, LOAC, FBSS, and CPAH Mergers
    GlobeNewswire

    SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of SNSS, LOAC, FBSS, and CPAH Mergers

    WILMINGTON, Del., Jan. 07, 2021 (GLOBE NEWSWIRE) -- Rigrodsky & Long, P.A. announces that it is investigating: Sunesis Pharmaceuticals, Inc. (NASDAQ CM: SNSS) regarding possible breaches of fiduciary duties and other violations of law related to Sunesis’ agreement to merge with Viracta. Under the terms of the agreement, Sunesis will issue a number of shares of Sunesis common stock to shareholders of Viracta. To learn more about this investigation and your rights, visit: https://www.rigrodskylong.com/cases-sunesis-pharmaceuticals-inc.Longevity Acquisition Corporation (NASDAQ GS: LOAC) regarding possible breaches of fiduciary duties and other violations of law related to Longevity’s agreement to merge with 4D Pharma PLC. Under the terms of the agreement, Longevity’s shareholders will receive 7.5315 ordinary shares of 4D Pharma per share. To learn more about this investigation and your rights, visit: https://www.rigrodskylong.com/cases-longevity-acquisition-corporation.Fauquier Bankshares, Inc. (NASDAQ GS: FBSS) regarding possible breaches of fiduciary duties and other violations of law related to Fauquier’s agreement to be acquired by Virginia National Bankshares Corporation. Under the terms of the agreement, Fauquier’s shareholders will 0.6750 shares of Virginia National common stock per share. To learn more about this investigation and your rights, visit: https://www.rigrodskylong.com/cases-fauquier-bankshares-inc.CounterPath Corporation (NASDAQ CM: CPAH) regarding possible breaches of fiduciary duties and other violations of law related to CounterPath’s agreement to be acquired by Alianza, Inc. Under the terms of the agreement CounterPath’s shareholders will receive $3.49 per share in cash. To learn more about this investigation and your rights, visit: https://www.rigrodskylong.com/cases-counterpath-corporation.You may also contact Seth D. Rigrodsky or Gina M. Serra cost and obligation free at (888) 969-4242 or info@rl-legal.com.Rigrodsky & Long, P.A., with offices in Delaware and New York, has recovered hundreds of millions of dollars on behalf of investors and achieved substantial corporate governance reforms in securities fraud and corporate class actions nationwide.Attorney advertising.  Prior results do not guarantee a similar outcome.CONTACT:         Rigrodsky & Long, P.A. Seth D. Rigrodsky Gina M. Serra (888) 969-4242 (Toll Free) (302) 295-5310 Fax: (302) 654-7530 info@rl-legal.com https://rl-legal.com

  • Longevity Acquisition Corporation Announces 4D pharma Joining Landmark Parkinson's Progression Markers Initiative
    PR Newswire

    Longevity Acquisition Corporation Announces 4D pharma Joining Landmark Parkinson's Progression Markers Initiative

    Longevity Acquisition Corporation (NASDAQ: LOAC) (the "Company"), a publicly-traded special purpose acquisition company, announced today that on December 18, 2020, 4D pharma plc (AIM: DDDD) ("4D pharma"), a pharmaceutical company leading the development of Live Biotherapeutic products ("LBPs") - a novel class of drug derived from the microbiome, and a business combination target of LOAC, has joined the Parkinson's Progression Markers Initiative ("PPMI") as an industry partner. PPMI is a landmark study sponsored by The Michael J. Fox Foundation to better understand Parkinson's disease and accelerate the development of new treatments.

  • SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of ELY, LOAC, ROCH, and NGA Mergers
    GlobeNewswire

    SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of ELY, LOAC, ROCH, and NGA Mergers

    WILMINGTON, Del., Dec. 17, 2020 (GLOBE NEWSWIRE) -- Rigrodsky & Long, P.A. announces that it is investigating:Callaway Golf Company (NYSE: ELY) regarding possible breaches of fiduciary duties and other violations of law related to Callaway’s agreement to merge with Topgolf International, Inc. Under the terms of the agreement Callaway will issue a number of shares of Callaway common stock to shareholders of Topgolf. To learn more about this investigation and your rights, visit: https://www.rigrodskylong.com/cases-callaway-golf-company.Longevity Acquisition Corporation (NASDAQ GS: LOAC) regarding possible breaches of fiduciary duties and other violations of law related to Longevity’s agreement to merge with 4D Pharma PLC. Under the terms of the agreement, Longevity’s shareholders will receive 7.5315 ordinary shares of 4D Pharma per share. To learn more about this investigation and your rights, visit: https://www.rigrodskylong.com/cases-longevity-acquisition-corporation.Roth CH Acquisition I Co. (NASDAQ GS: ROCH) regarding possible breaches of fiduciary duties and other violations of law related to Roth’s agreement to merge with PureCycle Technologies LLC. Under the terms of the agreement, upon completion of the merger, PureCycle’s shareholders will own approximately 70.6% of the combined company and shareholders of Roth will own approximately 8.3% of the combined company. To learn more about this investigation and your rights, visit: https://www.rigrodskylong.com/cases-roth-ch-acquisition-i-co.Northern Genesis Acquisition Corp. (NYSE: NGA) regarding possible breaches of fiduciary duties and other violations of law related to Northern Genesis’ agreement to merge with The Lion Electric Company. Under the terms of the agreement, upon completion of the merger, Lion Electric’s shareholders will own approximately 70% of the combined company. To learn more about this investigation and your rights, visit: https://www.rigrodskylong.com/cases-northern-genesis-acquisition-corp.You may also contact Seth D. Rigrodsky or Gina M. Serra cost and obligation free at (888) 969-4242 or info@rl-legal.com.Rigrodsky & Long, P.A., with offices in Delaware and New York, has recovered hundreds of millions of dollars on behalf of investors and achieved substantial corporate governance reforms in securities fraud and corporate class actions nationwide.Attorney advertising.  Prior results do not guarantee a similar outcome.CONTACT:         Rigrodsky & Long, P.A. Seth D. Rigrodsky Gina M. Serra (888) 969-4242 (Toll Free) (302) 295-5310 Fax: (302) 654-7530 info@rl-legal.com https://rl-legal.com